Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer
- Rietman, J.S.
- Geertzen, J.H.B.
- Hoekstra, H.J.
- Baas, P.
- Dolsma, W.V.
- Vries, J. de
- Groothoff, J.W.
- Eisma, W.H.
- Dijkstra, W.U.
DOIAbstract
Background:\ud In a prospective study, long term upper-limb morbidity, perceived disabilities in activities of daily life (ADL) and quality of life (QOL) were assessed before and 2 years after sentinel lymph node biopsy (SLNB) or axillary lymph node dissections (ALND) for breast cancer.\ud \ud Methods:\ud Two hundred and four patients with stage I/II breast cancer, mean age 55.6 years (SD: 11.6) entered the study and 181 patients (89%) could be evaluated after 2 years. Fifty-seven patients underwent SLNB (31%) and 124 patients underwent an ALND (69%). Assessments included pain, shoulder range of motion, muscle strength, arm volume, perceived shoulder disability in ADL and QOL.\ud \ud Results:\ud Significant (P<0.05) changes between before a...
Add to ORKG